Clinical Trials Directory

Trials / Completed

CompletedNCT05982340

Endogenous Lithium Clearance in Acute Kidney Injury

Status
Completed
Phase
Study type
Observational
Enrollment
20 (actual)
Sponsor
University Hospital of North Norway · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Critically ill patients are at high risk of developing acute kidney injury (AKI). Lithium is freely filtrated at the glomerulus and almost completely reabsorbed in the proximal tubule, which provides a quantitative estimation of proximal tubule reabsorption. The investigators hypothesized that endogenous lithium reabsorption is impaired in the early stages of critical illness. Investigators would like to study 10 ICU patients with AKI diagnosed, 10 patients without AKI, and 10 healthy controls.

Detailed description

Blood and urine samples will be obtained at 08:00, 14:00 and 20:00 during one day. Renal clearance of creatinine (CCr) and lithium will be calculated.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTLithium clearanceBlood and urine samples

Timeline

Start date
2023-08-01
Primary completion
2025-05-20
Completion
2025-05-20
First posted
2023-08-08
Last updated
2025-06-22

Locations

1 site across 1 country: Norway

Source: ClinicalTrials.gov record NCT05982340. Inclusion in this directory is not an endorsement.